Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
British Journal of Cancer
|
May 19, 2012
False-negative MRI biomarkers of tumour response to targeted cancer therapeutics
J K R Boult, Y Jamin, V Jacobs, et al.
Magnetic Resonance in Medicine
|
January 22, 2000
Diurnal variation in the femoral articular cartilage of the knee in young adult humans
J C Waterton, S Solloway, J E Foster, et al.
British Journal of Cancer
|
May 29, 2003
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging
S P Robinson, D J O McIntyre, D Checkley, et al.
British Journal of Cancer
|
August 15, 2013
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
M Beloueche-Babari, Y Jamin, V Arunan, et al.
Scientific Reports
|
April 13, 2017
Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation
S Skeoch, P L Hubbard Cristinacce, H Williams, et al.
European Radiology
|
September 29, 2017
Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives
N M deSouza, J M Winfield, J C Waterton, et al.
Magnetic Resonance in Medicine
|
March 26, 2011
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer
J H Naish, D M McGrath, L J Bains, et al.
British Journal of Cancer
|
May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
M O Leach, K M Brindle, J L Evelhoch, et al.
European Radiology
|
May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging
M O Leach, B Morgan, P S Tofts, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
British Journal of Cancer
|
May 19, 2012
False-negative MRI biomarkers of tumour response to targeted cancer therapeutics
J K R Boult, Y Jamin, V Jacobs, et al.
Magnetic Resonance in Medicine
|
January 22, 2000
Diurnal variation in the femoral articular cartilage of the knee in young adult humans
J C Waterton, S Solloway, J E Foster, et al.
British Journal of Cancer
|
May 29, 2003
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging
S P Robinson, D J O McIntyre, D Checkley, et al.
British Journal of Cancer
|
August 15, 2013
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
M Beloueche-Babari, Y Jamin, V Arunan, et al.
Scientific Reports
|
April 13, 2017
Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation
S Skeoch, P L Hubbard Cristinacce, H Williams, et al.
European Radiology
|
September 29, 2017
Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives
N M deSouza, J M Winfield, J C Waterton, et al.
Magnetic Resonance in Medicine
|
March 26, 2011
Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer
J H Naish, D M McGrath, L J Bains, et al.
British Journal of Cancer
|
May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
M O Leach, K M Brindle, J L Evelhoch, et al.
European Radiology
|
May 8, 2012
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging
M O Leach, B Morgan, P S Tofts, et al.
Page
of 5